In summary, IPA, produced by L. johnsonii and C. sporogenes, upregulates Tcf7 expression through histone acetylation, promotes the differentiation of CD8+ T cells into Tpex, and thereby strengthens anti-tumor immunity and the responsiveness to ICB therapy. Here, CD8A is linked to neoplasm.